Received Sep 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | ME6072 | IM / LA |
Suspected Giant Cell Myocarditis: 9/15: patient began feeling poorly with fever 9/18: patient presented to ED and admitted to the hospital 9/19: patient placed on VA-ECMO with IABP 9/24: VA-ECMO removed 9/26: IABP removed 9/26: ECG with Aflutter 9/27: Patient remains in ICU
gastroschisis and intestinal malrotation s/p surgical repair in infancy, sacroiliitis/ankylosing spondylitis (HLA B27 neg) on biologics at least since 2020: Golimumab (last infusion: 3/20/2025; prior treatment with Humira and Enbrel), chronic malnutrition on TPN
NKA
Tests: 7/06/2025: TTE with normal EF of 55-60% 9/19/2025: TTE with EF of 24%, TEE prior to VA-ECMO with EF of 10-15% 9/26/2025: TTE with EF of 35% while on dobutamine